Directory Calendar News Careers Alumni Giving

Prof. Jong H. Jeong, PhD

Professor and Interim Chair, Biostatistics


310 Parran Hall, 130 DeSoto Street, Pittsburgh, PA 15206
R-znvy: wwrbat@cvgg.rqh
Primary Phone: 967-179-3094
Secondary Phone: 967-179-8577
Fax: 967-179-7638

Personal Statement

My main research area has been time-to-event data analysis and clinical trials. In time-to-event data analysis, I have worked on frailty modeling, efficiency of survival probability estimates from the proportional hazards model, weighted log-rank test, competing risks, quantile residual lifetime, and likelihood theory such as empirical likelihood and hierarchical likelihood, which led to publication of my single-authored book with Springer, entitled Statistical Inference on Residual Life in 2014. 

In clinical trials, I have been involved in several influential phase III breast cancer clinical trials, including work on developing a prediction model based on microarray data collected from different platforms, through the National Surgical Adjuvant Breast and Bowel Project (NSABP) as a co-investigator. I direct Data Management and Statistical Unit (DMSU)  for the Division of General Academic Pediatrics, which also facilitates other senior investigators' research efforts in the Department of Pediatrics at large at Children’s Hospital of Pittsburgh of UPMC. I am also funded by Patient Centered Outcomes Research Institute (PCORI) projects, and collaborate with Cystic Fibrosis Center as a co-investigator. I am a senior faculty member in the Biostatistics, Epidemiology, Research and Design (BERD) core in the Clinical and Transnational Sciences Institute (CTSI) and in the Comparative Effectiveness Research Center (CERC) at University of Pittsburgh. 

I have graduated 5 MS and 10 PhD students, and am currently advising 2 PhD students. I have been teaching statistical theory and survival analysis courses. I currently serve on the editorial board for the journal of Lifetime Data Analysis, a well-respected journal dedicated to time-to-event data analysis. I am a Fellow of the American Statistical Association (ASA), an elected member of the International Statistical Institute (ISI), and an elected member of Omicron of the Delta Omega Society (Honorary Public Health Society).


1996 | University of Rochester, Rochester, NY | PhD in Statistics


BIOST 2043: Introduction to Statistical Theory I
BIOST 2044: Introduction to Statistical Theory II
BIOST 2049: Applied Regression Analysis
BIOST 2051: Statistical Estimation Theory
BIOST 2054/STAT 2261: Survival Analysis
BIOST 2066: Applied Survival Analysis

Selected Publications



  1. Ha I., Jeong, J., Lee, Y. (2017). Statistical Modelling of Survival Data with Random Effects: H-likelihood Approach. Springer, In press.
  2. Jeong, J. (2014). Statistical Inference on Residual Life. Springer: New York.

Peer-reviewed papers

  1. Oakes, D. and Jeong, J.  (1998). Frailty models and rank tests.  Lifetime Data Analysis, 4, 209-228.
  2. Jeong, J. and Oakes, D. (2003). On the asymptotic relative efficiency of estimates from Cox’s model. Sankhya, 65,411-421.
  3. Jeong, J. and Fine, J. (2006). Direct parametric inference for cumulative
    incidence function. Journal of Royal Statistical Society-Series C (Applied Statistics) 55, 187-200.
  4. Jeong, J. (2006). A new parametric distribution for modeling cumulative
    incidence function: Application to breast cancer data. Journal of Royal Statistical Society-Series A (Statistics in Society). 169, 289-303.
  5. Jeong, J. and Jung, S. (2006). Rank tests for clustered survival data when dependent subunits are randomized. Statistics in Medicine. 25, 361-373.
  6. Jeong, J. and Fine, J. (2007). Parametric regression on cumulative incidence function. Biostatistics 8, 184-196.
  7. Jeong, J., Jung, S, and Joseph Costantino. (2008). Nonparametric inference on  median residual lifetimes in breast cancer patients. Biometrics 64, 157-163.
  8. Jung, S., Jeong, J., and Bandos, H. (2009). Regression on quantile residual life. Biometrics 65, 1203-1212.
  9. Jeong, J. and Fine, J.P. (2009). A note on quantile residual life under competing risks. Biometrika 96, 237-242.
  10. Zhou, M. and Jeong, J. (2011). Empirical likelihood ratio test for median and mean residual lifetime. Statistics in Medicine 30, 152-159.
  11. Tang, S. and Jeong, J. (2012). Median tests for censored survival data; a contingency table approach. Biometrics 68, 983-989.
  12. Park, T., Jeong, J., and Lee, J. (2012). Nonparametric Bayesian inference on quantile
    residual life function. Statistics in Medicine 31, 1972–1985.
  13. Ha, I., Christian, N., Jeong, J., Park, J., and Lee, Y. (2014). Analysis of clustered competing risks data using subdistribution hazard models with multivariate frailties. Statistical Methods in Medical Research, DOI: 10.1177/0962280214526193.
  14. Balmert, L. and Jeong, J. (2016). Nonparametric inference on quantile lost lifespan. Biometrics, in press.
  15. Fisher, B, Jeong, J., Anderson, S. Bryant, J., Fisher, E., and Wolmark Norman. (2002). Twenty-five year findings from a randomized clinical trial comparing radical mastectomy with total mastectomy and with total mastectomy followed by radiation therapy. New England Journal of Medicine, vol. 347, 8, 567-575.
  16. Fisher, B., Jeong,J., Bryant, J., Mamounas, E.P., Dignam, J., and Wolmark, N. (2004)
    Treatment of lymph node-negative, estrogen receptor-positive breast cancer:
    long-term findings from National Surgical Adjuvant Breast and Bowel Project
    clinical trials. Lancet, 364, 858-868.
  17. Mell, L. and Jeong, J. (2010). Pitfalls of using composite primary end points in the presence of competing risks. Journal of Clinical Oncology, 28:4297-4299.
  18. Romond, E, Jeong, J, Rastogi, P. et al. (2012). Seven year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide Followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, Human Epidermal Growth Factor Receptor 2-positive breast cancer. Journal of Clinical Oncology 30, 3792-3799.
  19. Pogue-Geile, K.L., Kim, C., Jeong, J. et al. (2013). Predicting degree of benefit from adjuvant trastuzumab in NSABP Trial B-31. Journal of the National Cancer Institute, 105, 1782-1788. 

Jong H. Jeong
© 2017 by University of Pittsburgh Graduate School of Public Health

Login  |  Sitemap